On ECHEMI
Home > Drugs > Methylene Blue Injection

Methylene Blue Injection

Function and Efficacy

Methylene blue itself is an oxidant, and it has two different effects on hemoglobin depending on its concentration in the body. At low concentrations, hydrogen ions in the dehydrogenation process of 6-phosphate-glucose are transferred to methylene blue through reduced triphosphate pyridine nucleoside, converting it into reduced white methylene blue; white methylene blue then transfers hydrogen ions to methemoglobin with trivalent iron, reducing it to normal hemoglobin with divalent iron, and white methylene blue is oxidized to methylene blue. The reduction-oxidation process of methylene blue can be repeated. At high concentrations, methylene blue cannot be completely reduced to white methylene blue, so it has an oxidizing effect, oxidizing normal hemoglobin to methemoglobin. Since methemoglobin easily combines with CN- to form cyanomethemoglobin, but the two dissociate again after a few minutes, it can only temporarily inhibit the toxicity of CN- to tissue poisoning.

Ingredients

Ingredients: Methylene blue. Chemical name: 3,7-bis(dimethylamino)phenothiatin-5-ium chloride trihydrate.

Name Description Content CAS NO. Manufacturer
Methylene Blue trihydrateIngredients

At low concentrations, methemoglobin can be reduced to normal hemoglobin; at high concentrations, normal hemoglobin can be oxidized to methemoglobin, thereby temporarily inhibiting the toxicity of CN- to tissues.

More
7220-79-3 8

Indication

This product is effective for methemoglobinemia caused by chemicals such as nitrite, nitrate, aniline, nitrobenzene, trinitrotoluene, benzoquinone, phenylhydrazine, etc. and drugs containing or producing aromatic amines (acetanilide, acetaminophen, phenacetin, benzocaine, etc.). It is less effective for methemoglobinemia caused by congenital reduced diphosphate pyridine nucleoside methemoglobin reductase deficiency. It is ineffective for abnormal hemoglobin M accompanied by methemoglobinemia. It can temporarily delay the toxicity of acute cyanide poisoning.

Usage and Dosage

Intravenous injection: 1-2 mg/kg of body weight for nitrite poisoning, 5-10 mg/kg of body weight for cyanide poisoning, and the maximum dose is 20 mg/kg.

Adverse Reactions

Intravenous injection of this product too quickly can cause dizziness, nausea, vomiting, chest tightness, abdominal pain, and excessive dosage. In addition to the aggravation of the above symptoms, headaches, lowered blood pressure, increased heart rate with arrhythmia, profuse sweating and impaired consciousness may also occur. After taking the drug, the urine will be blue and there may be stinging pain in the urethra during urination.

Drug Interactions

Not yet clear.

Storage

Keep away from light and store in a sealed container.

Packaging Specification

10ml:0.1g

Manufacturer

Jumpcan Pharmaceutical Group Co., Ltd.

  • Founded in:

    1994-05-03
  • Address:

    Baota Bay, Daqing West Road, Taixing City
  • Tax NO.:

    913212831411793153
  • Registered Funds:

    300 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.